Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
S Afr Med J ; 111(8): 720-723, 2021 Jun 08.
Article in English | MEDLINE | ID: covidwho-1355170

ABSTRACT

Herbal medicines made from the bark of the Cinchona tree, and later quinine, have been widely used for centuries to treat medical conditions such as tropical malaria. More recently, chloroquine (CQ) and its synthetic derivatives have been used as antimalarials and to treat systemic lupus erythematosus, rheumatoid arthritis, and in the past 14 months or so, COVID-19 pneumonia. Anecdotal evidence and the erratic covering through social media of its potential efficacy in the treatment of COVID-19 pneumonia have resulted in the widespread off-label use of CQ in South Africa and worldwide. This study aimed to show that access to CQ as a chronic medication for rheumatic and musculoskeletal diseases was limited during the COVID-19 pandemic, and that this resulted in an increased incidence of flares in these patients, affecting their morbidity and potentially leading to mortality.


Subject(s)
Chloroquine/pharmacology , Rheumatology/standards , Ambulatory Care Facilities/organization & administration , Ambulatory Care Facilities/statistics & numerical data , Antirheumatic Agents/pharmacology , Antirheumatic Agents/therapeutic use , COVID-19/drug therapy , Chloroquine/therapeutic use , Humans , Musculoskeletal Diseases/drug therapy , Rheumatic Diseases/drug therapy , Rheumatology/methods , Rheumatology/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL